Autoantibodies before, during and after administration of recombinant interferon-alpha for chronic viral hepatitis
6
0
0
Texto
Documentos relacionados
The mechanisms that determine viral clearance or viral persistence in chronic viral hepatitis have yet to be identified. Recent advances in molecular genetics have permitted
[r]
In this step, items 14 (You were encouraged to put your baby in skin-to-skin contact immediately after delivery) and 15 (In the first hour after de- livery you kept your baby
The objective of the present study was to determine whether the expression of mRNA for subunit 1 of the IFN- α receptor (IFNAR1) in peripheral blood mononuclear cells (PBMC)
In patients with HbeAg-negative chronic hepatitis B HBsAg serum levels early during treatment with peginterferon alpha-2a predict H BsAg clearance 4 years postreatment
Os resultados mostraram níveis de Hb mais elevados no grupo Após-foriicação em todos os meses de gesta- ção, exceto no início (<3º mês) e inal da gestação (≥8º
Extended (2 years) treatment with peginterferon alfa-2a (40KD) improves sustained response rates in genotype D patients with HBeAg-negative chronic
[r]
